Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
tetanus and diphtheria toxoids vaccine
- Development stage
- Approved
- Lead developer
- MassBiologics
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Tetanus and diphtheria toxoids vaccine (Td) is a combination vaccine used for active immunization to prevent infections caused by *Clostridium tetani* (tetanus) and *Corynebacterium diphtheriae* (diphtheria). The vaccine contains inactivated toxins (toxoids) from both bacteria that stimulate the immune system to produce protective antibodies without causing disease. It is indicated for use in adults and children at least 7 years old. The mechanism of action involves induction of immunity through exposure to the detoxified bacterial toxins, leading to antibody production that neutralizes the effects of natural infection[1][3][5][8].
- Brand names
- TDVAXTenivacTetanus-Diphtheria Toxoids AdultDecavac
- Other names
- tetanus diphtheria toxoidTd vaccinediphtheria and tetanus toxoids adsorbed
02
Targets
Diphtheria toxin
Beyond the preview
Go deeper on tetanus and diphtheria toxoids vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on tetanus and diphtheria toxoids vaccine.